MedTrace Logo

Long-Term Follow-up Protocol

NCT04917887 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-06-08

No results posted yet for this study

Summary

The main objective of this prospective, observational, long-term follow-up (LTFU) study is to evaluate the long-term safety profile of the gene therapy products evaluated by Krystal Biotech, Inc. which have a shared backbone of HSV-1, in participants who received at least one dose of investigational product (IP).

Conditions

Sponsors & Collaborators

  • Krystal Biotech, Inc.

    lead INDUSTRY

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-25
Primary Completion
2028-05-25
Completion
2028-05-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04917887 on ClinicalTrials.gov